CROHNS-DISEASE (CD) PATIENTS SUFFERING FROM PERIPHERAL ARTHRITIS OR ANKYLOSING-SPONDYLITIS REVEAL RESTRICTED T-CELL RECEPTOR V-BETA REGIONSIN DIFFERENT TEMPORAL PHASES OF DISEASE
N. Lugering et al., CROHNS-DISEASE (CD) PATIENTS SUFFERING FROM PERIPHERAL ARTHRITIS OR ANKYLOSING-SPONDYLITIS REVEAL RESTRICTED T-CELL RECEPTOR V-BETA REGIONSIN DIFFERENT TEMPORAL PHASES OF DISEASE, Clinical and experimental immunology, 105(2), 1996, pp. 278-284
Little is known about the mechanisms triggering and controlling both t
he development and perpetuation of extraintestinal complications in CD
. The aim of the present study was to test the hypothesis that the T c
ell immune response in CD patients with joint complications may be alt
ered when compared with patients without extraintestinal manifestation
s. We used a semiquantitative polymerase chain reaction assay to analy
se the T cell antigen receptor repertoire in peripheral blood T cells
from eight CD patients suffering from peripheral arthritis and ankylos
ing spondylitis, 12 CD patients without extraintestinal manifestations
, and from seven non-CD patients with ankylosing spondylitis showing t
ypical changes on joint radiographs. Being concerned that different pa
tterns may be seen in different phases of the inflammatory disease pro
cess, we have also taken care to analyse sequential samples at various
time points of the disease. Expression of all 22V beta genes was foun
d in each healthy control and in each CD patient without extraintestin
al manifestations and showed no major variation over time. Southern hy
bridization analysis of amplified products revealed a highly restricte
d V beta repertoire in all CD patients suffering from peripheral arthr
itis and ankylosing spondylitis. In contrast, non-CD patients with ank
ylosing spondylitis without signs or symptoms of gastrointestinal prob
lems demonstrated the presence of the entire V beta repertoire. Our lo
ngitudinal studies confirmed variable V beta usage over time, as certa
in transcripts were found only in distinct temporal phases of disease.
Our data are not directly suggestive of a common superantigen model o
f CD, but instead emphasize a specific decrease in signals throughout
the T cell receptor V beta repertoire in CD patients suffering from jo
int complications.